Raphael Anthony Reyes, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Malaria, Falciparum | 5 | 2024 | 1077 | 1.730 |
Why?
|
Antibodies, Protozoan | 5 | 2024 | 252 | 1.490 |
Why?
|
Plasmodium falciparum | 6 | 2024 | 1742 | 1.270 |
Why?
|
Merozoites | 2 | 2024 | 61 | 1.000 |
Why?
|
Antigens, Protozoan | 2 | 2024 | 316 | 0.990 |
Why?
|
Malaria Vaccines | 2 | 2024 | 165 | 0.980 |
Why?
|
Protozoan Proteins | 3 | 2024 | 847 | 0.920 |
Why?
|
Receptors, Fc | 2 | 2021 | 535 | 0.750 |
Why?
|
Virulence Factors | 1 | 2024 | 513 | 0.730 |
Why?
|
Virulence | 1 | 2024 | 1303 | 0.720 |
Why?
|
T-Box Domain Proteins | 1 | 2021 | 469 | 0.650 |
Why?
|
Malaria | 3 | 2023 | 1227 | 0.630 |
Why?
|
Merozoite Surface Protein 1 | 2 | 2024 | 38 | 0.440 |
Why?
|
Immunologic Memory | 3 | 2024 | 1359 | 0.390 |
Why?
|
B-Lymphocytes | 3 | 2024 | 4758 | 0.240 |
Why?
|
Receptors, Antigen, B-Cell | 3 | 2024 | 545 | 0.240 |
Why?
|
Immunoglobulin M | 4 | 2022 | 1526 | 0.230 |
Why?
|
Immunoglobulin G | 5 | 2022 | 4544 | 0.230 |
Why?
|
Antibody Affinity | 1 | 2024 | 246 | 0.220 |
Why?
|
Germinal Center | 1 | 2024 | 380 | 0.190 |
Why?
|
Microvessels | 1 | 2024 | 577 | 0.180 |
Why?
|
Antigens, Surface | 1 | 2024 | 1606 | 0.180 |
Why?
|
HIV Antibodies | 1 | 2024 | 1303 | 0.140 |
Why?
|
Immunity, Humoral | 1 | 2020 | 606 | 0.130 |
Why?
|
Binding Sites | 1 | 2024 | 6056 | 0.130 |
Why?
|
Erythrocytes | 1 | 2024 | 2413 | 0.120 |
Why?
|
Models, Molecular | 1 | 2024 | 5439 | 0.120 |
Why?
|
Protein Binding | 1 | 2024 | 9353 | 0.100 |
Why?
|
Flow Cytometry | 1 | 2021 | 5870 | 0.090 |
Why?
|
Antibodies, Viral | 1 | 2021 | 3156 | 0.090 |
Why?
|
Antibodies, Monoclonal | 1 | 2024 | 9177 | 0.070 |
Why?
|
HIV-1 | 1 | 2024 | 6863 | 0.070 |
Why?
|
Phenotype | 1 | 2024 | 16592 | 0.070 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15843 | 0.060 |
Why?
|
Gene Knock-In Techniques | 1 | 2024 | 421 | 0.050 |
Why?
|
Humans | 9 | 2024 | 761596 | 0.050 |
Why?
|
Hospitalization | 1 | 2021 | 10721 | 0.050 |
Why?
|
Adult | 4 | 2024 | 221210 | 0.050 |
Why?
|
Animals | 3 | 2024 | 168475 | 0.040 |
Why?
|
Young Adult | 1 | 2024 | 59260 | 0.040 |
Why?
|
AIDS Vaccines | 1 | 2024 | 896 | 0.040 |
Why?
|
Brain | 1 | 2024 | 27121 | 0.040 |
Why?
|
Antibody Formation | 1 | 2022 | 1395 | 0.040 |
Why?
|
Uganda | 1 | 2022 | 1332 | 0.040 |
Why?
|
Male | 2 | 2024 | 360846 | 0.030 |
Why?
|
Antibodies, Neutralizing | 1 | 2024 | 1943 | 0.030 |
Why?
|
Female | 2 | 2024 | 392705 | 0.030 |
Why?
|
Mice, Transgenic | 1 | 2024 | 9542 | 0.020 |
Why?
|
Recurrence | 1 | 2021 | 8466 | 0.020 |
Why?
|
Aged | 1 | 2021 | 169310 | 0.020 |
Why?
|
Middle Aged | 1 | 2021 | 220921 | 0.020 |
Why?
|
Chronic Disease | 1 | 2021 | 9319 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2024 | 22174 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2021 | 14608 | 0.020 |
Why?
|
Child, Preschool | 1 | 2021 | 42232 | 0.010 |
Why?
|
HIV Infections | 1 | 2024 | 17354 | 0.010 |
Why?
|
Mice | 1 | 2024 | 81539 | 0.010 |
Why?
|
Child | 1 | 2022 | 80158 | 0.010 |
Why?
|